Selective A2 Adenosine Receptor Agonists with Potent Inhibitory Activity on Platelet Aggregation

  • Gloria Cristalli
  • Emidio Camaioni
  • Sauro Vittori
  • Rosaria Volpini

Abstract

Recently, we have reported on the synthesis of the 2-hexynyl derivative of NECA, N-ethyl-l’deoxy-1’ -(6-amino-2-hexynyl-9H-purin-9-yl)-ßribofuranuronamide, identified as HENECA (Fig. 17-1), which was shown to possess high affinity at A2 adenosine receptors combined with a good A2 versus A1 selectivity[1]Table 17-1 shows the ability of HENECA to inhibit the binding of radioligands to A1 and A2 receptors compared with that of NECA [2], 2-[[4-(2carboxyethyl) phenethyllamino) adenosine-5’N-ethyluronamide (CGS 21680) [3]and of the selective A1 agonist 2-chloro-N6-cyclopentyladenosine (CCPA) [4] In the same table the effects of these compounds on the stimulation of platelet and PC 12 cell membrane adenylate cyclase are also shown [5]. The results of the cyclase assays are in good agreement with the higher affinity of HENECA of the A2 receptors compared with the other adenosine agonists listed in Table 17-1.

Keywords

Adenosine Pyrane Benzyl Nucleoside HCooH 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cristalli G, Eleuteri A, Vittori S, Volpini R, Lohse MJ, Klotz K-N (1992) 2-Alkynyl derivatives of adenosine and adenosine-5’-N-ethyluronamide as selective agonists at A2 adenosine receptors. J Med Chem 35:2363–2368.PubMedCrossRefGoogle Scholar
  2. 2.
    Bruns RF, Lu GH, Pugsley TA (1986) Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 29:331–346.PubMedGoogle Scholar
  3. 3.
    Hutchison AJ, Webb RL, Oei HH, Ghai GR, Zimmerman MB, Williams M (1989) CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251:47–55.PubMedGoogle Scholar
  4. 4.
    Dionisotti S, Zocchi C, Varani K, Borea PA, Ongini E (1992) Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn Schmiedebergs Arch Pharmacol 347:673–676.Google Scholar
  5. 5.
    Gristalli G, Vittori S, Thompson RD, Padgett WL, Sci D, Daly JW, Olsson RA (1994) Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn Schmiedebergs Arch Pharmacol 349:644–650.CrossRefGoogle Scholar
  6. 6.
    Conti A, Monopoli A, Gamba M, Borea PA, Ongini E (1993) Effect of selective A1 and A2 adenosine receptor agonists on cardiovascolar tissues. Naunyn Schmiedebergs Arch Pharmacol 347:647–676.Google Scholar
  7. 7.
    Sandoli D, Chiu PJS, Chintala M, Dionisotti S, Ongini E (1994) In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit. Eur J Pharmacol, in press.Google Scholar
  8. 8.
    Cristalli G, Volpini R, Vittori S, Camaioni E, Monopoli A, Conti A, Dionisotti S, Zocchi C, Ongini E (1994) 2-Alkynyl derivatives of adenosine-5’-N-ethyluronamide (NECA): Selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J Med Chem 37:1720–1726.PubMedCrossRefGoogle Scholar
  9. 9.
    Matsuda A, Shinozaki M, Miyasaka T, Machida H, Abiru T (1985) Palladium-catalized cross-coupling of 2-iodoadenosine with therminal alkynes: Synthesis and biological activities of 2-alkynyladenosines. Chem Pharm Bull 33: 2551–2554.Google Scholar
  10. 10.
    Jarvis MF, Schultz R, Hutchison AJ, Do UH, Sills MA, Williams M (1989) [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther 251:888–893.PubMedGoogle Scholar
  11. 11.
    Bruns RF, Daly JW, Snyder SH (1980) Adenosine receptors in brain membranes: Binding of N6-cyclohexyl-[3H]adenosine and 1,3-diethyl-8[3H]phenylxanthine. Proc Natl Acad Sci USA 77:5547–5541.PubMedCrossRefGoogle Scholar
  12. 12.
    Lohse MJ, Klotz K-N, Schwabe U, Cristalli G, Vittori S, Grifantini M (1988) 2-Chloro-N6cyclopentyladenosine: A highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 337:687–689.PubMedGoogle Scholar
  13. 13.
    Brent DA, Sabatka JJ, Minick DJ, Henry DW (1983) A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships. J Med Chem 26:1014–1020.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Gloria Cristalli
  • Emidio Camaioni
  • Sauro Vittori
  • Rosaria Volpini

There are no affiliations available

Personalised recommendations